Telbivudine

CHEMBL374731 Phase 4 承認済み Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

242.2 g/mol

LogP

-1.2

Phase

4

This antiviral medication is used to treat chronic hepatitis B infection by blocking the virus from copying itself inside liver cells. It helps reduce the amount of hepatitis B virus in the blood and lowers the risk of liver damage and complications. Long-term use requires monitoring of liver function and muscle health.

分子量

242.2300 g/mol

LogP

-1.20

TPSA

99.10 Å²

リピンスキーの五則

適合

治療領域

Ovarian Cancer Pancreatic Cancer Bladder Cancer Thyroid Cancer Non-Small Cell Lung Cancer Chronic Kidney Disease Lymphoma Hypertension Major Depressive Disorder Breast Cancer Hepatitis C Prostate Cancer Colorectal Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure

Embed this structure

SMILES

Cc1cn([C@@H]2C[C@@H](O)[C@H](CO)O2)c(=O)[nH]c1=O

InChI

InChI=1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16)/t6-,7+,8+/m1/s1

Molecular Formula

C10H14N2O5

HBD / HBA

3 / 5

回転可能結合数

2

重原子数

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

This antiviral medication is used to treat chronic hepatitis B infection by blocking the virus from copying itself inside liver cells. It helps reduce the amount of hepatitis B virus in the blood and lowers the risk of liver damage and complications. Long-term use requires monitoring of liver function and muscle health.

Yes, Telbivudine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL374731. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 159269. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

患者向けのわかりやすい情報をお探しですか？

Telbivudine PillFYIで

構造

クイックデータ

分子式: C10H14N2O5

外部リンク

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.